APA (7th ed.) Citation

Waheed, M. T., Ruel, N., Whelan, R. L., Fakih, M., Fong, Y., Deperalta, D., . . . Raoof, M. (2025). ASO Visual Abstract: Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in Refractory Colorectal and Appendiceal Carcinomatosis—Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial: PIPAC vs ST for PM; Good days & Survival. Annals of surgical oncology, 32(2), 709. https://doi.org/10.1245/s10434-024-16187-8

Chicago Style (17th ed.) Citation

Waheed, Muhammad Talha, et al. "ASO Visual Abstract: Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in Refractory Colorectal and Appendiceal Carcinomatosis—Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial: PIPAC Vs ST for PM; Good Days & Survival." Annals of Surgical Oncology 32, no. 2 (2025): 709. https://doi.org/10.1245/s10434-024-16187-8.

MLA (9th ed.) Citation

Waheed, Muhammad Talha, et al. "ASO Visual Abstract: Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in Refractory Colorectal and Appendiceal Carcinomatosis—Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial: PIPAC Vs ST for PM; Good Days & Survival." Annals of Surgical Oncology, vol. 32, no. 2, 2025, p. 709, https://doi.org/10.1245/s10434-024-16187-8.